Loperamide: A positive modulator for store-operated calcium channels?

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 26, 1997, Pages 14912-14917

  Harper, Jacquie L ^a   Shin, Yangmee ^a   Daly, John W ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ATP; Inositol trisphosphate; Phorbol ester; Thapsigargin; Trifluoperazine

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM CHANNEL; CLOTRIMAZOLE; INOSITOL TRISPHOSPHATE; IONOMYCIN; LOPERAMIDE; MICONAZOLE; NITRENDIPINE; SPHINGOSINE; THAPSIGARGIN; TRIFLUOPERAZINE;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; HUMAN; HUMAN CELL; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

3T3 CELLS; ANIMALS; CALCIUM; CALCIUM CHANNELS; HL-60 CELLS; HUMANS; ION CHANNEL GATING; LOPERAMIDE; MICE;

EID: 0031434344     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.26.14912     Document Type: Article

References (25)

1. Putney, J. W., Jr. (1986) Cell Calcium 7, 1-12.
2. Berridge, M. J. (1995) Biochem. J. 312, 1-11.
3. Clementi, E. & Meldolesi, J. (1996) Cell Calcium 19, 269-279.
4. Mason, M. J., Mayer, B. & Hymel, L. J. (1993) Am. J. Physiol. 264, 654-662.
5. Gericke, M., Oike, M., Droogmans, G. & Nilius, B. (1994) Eur. J. Pharmacol. 269, 381-384.
6. Daly, J. W., Lueders, J., Padgett, W. L., Shin, Y. & Gusovsky, F. (1995) Biochem. Pharmacol. 50, 1187-1197.
7. Quik, M., Choremis, J., Komourian, J., Lukas, R. J. & Puchacz, E. (1996) J. Neurochem. 67, 145-154.
8. Mogensen, H. S. & Jorgensen, O. S. (1996) Neurochem. Int. 29, 497-506.
9. Grynkiewitz, G., Poenie, M. & Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450.
10. Awouters, F., Niemegeers, J. E. & Janssen, P. A. J. (1983) Annu. Rev. Pharmacol. Toxicol. 23, 279-301.
11. Ooms, L. A. A., Degryse, A. & Janssen, P. A. J. (1984) Scand. J. Gastroenterol. Suppl. 96, 145-155.
12. Burleigh, D. E. (1988) Eur. J. Pharmacol. 152, 39-46.
13. Zavez, J. H., Jackson, T. E., Limp, G. L. & Yellin, T. O. (1982) Eur. J. Pharmacol. 78, 375-377.
14. Diener, M., Knobloch, S. F. & Rummel, W. (1988) Eur. J. Pharmacol. 152, 217-225.
15. Reynolds, I. J., Gould, R. J. & Snyder, S. H. (1984) J. Pharmacol. Exp. Ther. 231, 626-631.
16. Church, J., Fletcher, E. J., Abdel-Hamid, K. & MacDonald, J. F. (1994) Mol. Pharmacol. 45, 747-757.
17. Inesi, G. & Sagara, Y. (1992) Arch. Biochem. Biophys. 298, 313-317.
18. Montero, M., Alvarez, J. & Garcia-Sancho, J. (1991) Biochem. J. 277, 73-79.
19. Shin, Y., Daly, J. W. & Jacobson, K. A. (1996) Drug Dev. Res. 39, 36-46.
20. Encabo, A., Romanin, C., Birke, F. W., Kukovetz, W. R. & Groschner, K. (1996) Br. J. Pharmacol. 119, 702-706.
21. Ghosh, T. K., Bian, J. & Gill, D. L. (1990) Science 248, 1653-1656.
22. Ghosh, T. K., Bian, J. & Gill, D. L. (1994) J. Biol. Chem. 269, 22628-22635.
23. Zweifach, A. & Lewis, R. S. (1995) J. Biol. Chem. 270, 14445-14451.
24. Ribeiro, C. M. P. & Putney, J. W., Jr. (1996) J. Biol. Chem. 271, 21522-21528.
25. Marriott, I. & Mason, M. J. (1996) J. Biol. Chem. 271, 26732-26738.